Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion type Assertion NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_head.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion evidence source_evidence_literature NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion SIO_000772 20237793 NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion wasDerivedFrom befree-20150227 NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.
- NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion wasGeneratedBy ECO_0000203 NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.